Last edition
News about "immuno-oncology"
Innovent Doses First Patient in Pivotal IBI363/TAK-928 CRC Study
Innovent has dosed the first patient in its pivotal IBI363/TAK-928 study, advancing next-generation immunotherapy for colorectal cancer.
Immuno-oncology | 06/08/2026 | By News Bureau | 206
ModeX Therapeutics Doses First Patients in Trial of Novel Tetraspecific Therapy for B-Cell Lymphoma
ModeX Therapeutics initiates clinical testing of MDX2003, a next-generation multispecific antibody therapy designed to enhance immune response and improve outcomes in B-cell lymphoma patients.
Immuno-oncology | 24/04/2026 | By News Bureau | 127
BioMed X Launches First Research Team in France to Advance AI-Driven Antibody Design
BioMed X launches AI-focused antibody research team in France, aiming to accelerate development of next-generation biologic therapies for cancer and immune diseases.
Immuno-Oncology | 21/04/2026 | By News Bureau | 123
The collaboration between Boehringer Ingelheim and BioNTech will evaluate a dual immuno-oncology approach in extensive-stage small cell lung cancer, aiming to improve outcomes in a disease with limited treatment options.
Immuno-oncology | 11/04/2026 | By News Bureau | 132
Mabtech, Sai Life Sciences Partner to Expand Advanced Immunology Services in the U.S.
Mabtech and Sai Life Sciences collaborate to deploy EYRA multiplex platform in Boston, enhancing access to advanced immune profiling for biopharma and biotech research.
Immuno-oncology | 19/03/2026 | By News Bureau | 206
Zydus Launches World's First Nivolumab Biosimilar 'Tishtha' in India
Zydus Lifesciences has launched Tishtha, the world’s first biosimilar of the immunotherapy drug nivolumab, in India, aimed at expanding access to advanced cancer care by offering the treatment at nearly one-fourth the cost of the reference product for patients with multiple cancer types.
Immuno-oncology | 23/01/2026 | By News Bureau | 881
Bridge Biotherapeutics New Venture into Immuno-Oncology with University of Colorado
Bridge Biotherapeutics has forged a research collaboration with Dr. Raul Torres's Lab at the University of Colorado School of Medicine.
Immuno-oncology | 27/03/2024 | By Manvi | 579
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy